<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01757821</url>
  </required_header>
  <id_info>
    <org_study_id>BrainPrime</org_study_id>
    <nct_id>NCT01757821</nct_id>
  </id_info>
  <brief_title>Primed vs. Unprimed rTMS in Chronic Stroke</brief_title>
  <official_title>6-Hz Primed vs. Unprimed Low-Frequency rTMS in Chronic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of stroke rehabilitation is to restore function to the weak side of the body.&#xD;
      However, this is often a difficult task to accomplish due to not only to damage from the&#xD;
      stroke, but from increased excitability in the non-stroke side of the brain that inhibits the&#xD;
      stroke side from functioning optimally. Repetitive transcranial magnetic stimulation (rTMS)&#xD;
      is a non-invasive form of brain stimulation that can enhance excitability in the stroke side&#xD;
      when applied at a low-frequency on the non-stroke side. By &quot;inhibiting the inhibition&quot; (i.e.&#xD;
      disinhibition), rTMS promotes adaptive brain reorganization following stroke. Previous&#xD;
      research in healthy individuals demonstrates enhanced effects of low-frequency rTMS when it&#xD;
      is preceded by high-frequency (excitatory) rTMS stimulation known as priming. Our lab&#xD;
      previously demonstrated the safety of 6-Hz priming with low-frequency rTMS in both adults and&#xD;
      children with chronic stroke. However, it is currently unknown whether or not the addition of&#xD;
      priming stimulation to low-frequency rTMS enhances excitability in the stroke hemisphere. Our&#xD;
      study will examine three rTMS interventions in twelve adults (at least 18 years): 1.) 10&#xD;
      minutes of real priming followed by 10 minutes of low-frequency rTMS, 2.) 10 minutes of fake&#xD;
      priming followed by 10 minutes of low-frequency rTMS, 3.) 20 minutes of low-frequency rTMS&#xD;
      only. Participants will receive all three interventions in randomized order. Each week,&#xD;
      participants will complete two pretest and 3 posttest sessions consisting of behavioral&#xD;
      measures of weak upper extremity function and cortical excitability in addition to receiving&#xD;
      one rTMS intervention. Following each week of testing and treatment, subjects will take a one&#xD;
      week rest break before crossing-over to receive another intervention. We hypothesize the&#xD;
      following: 1.) Primed rTMS will result in significantly reduced inhibition and significantly&#xD;
      increased excitation on the stroke side vs. fake primed rTMS or low-frequency rTMS given&#xD;
      alone and 2.) Primed rTMS will result in greater improvements of paretic hand function. This&#xD;
      study is innovative in that it intends to compare primed and unprimed rTMS in the stroke&#xD;
      brain that could acknowledge a more effective delivery method of rTMS to potentially yield&#xD;
      greater rehabilitative outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recovery following stroke is difficult not only because of the neuronal death from the&#xD;
      ischemic insult but also because of maladaptive brain reorganization occurring from&#xD;
      exaggerated inhibition imparted by the over-compensating contralesional primary motor area&#xD;
      (M1) onto the ipsilesional M1 via transcallosal pathways. Advancement in stroke&#xD;
      rehabilitation depends on innovative treatments like repetitive transcranial magnetic&#xD;
      stimulation (rTMS) that possess the ability to disrupt this excessive inhibition. Through&#xD;
      previous NIH/NICHD funding, my sponsor's research team confirmed the safety and efficacy of&#xD;
      rTMS in both adult (1R01 HD053153-01A2) and children (1RC1 HD063838-01) with stroke using&#xD;
      6-Hz primed low-frequency rTMS applied to the contralesional M1 to produce disinhibition of&#xD;
      the ipsilesional M1. With feasibility of primed rTMS now demonstrated, the proposed research&#xD;
      plan will directly compare primed rTMS to unprimed rTMS. The investigators will investigate&#xD;
      whether pretreatment of inhibitory low-frequency rTMS with excitatory high-frequency priming&#xD;
      is more effective than sham-primed low-frequency rTMS in correcting the exaggerated&#xD;
      interhemispheric inhibition acting on ipsilesional M1. While this may sound contradictory,&#xD;
      the Bienenstock-Cooper-Munro theory of bidirectional plasticity supports this concept. The&#xD;
      long-term goal is to discover the most effective rTMS protocol with which to safely&#xD;
      up-regulate ipsilesional M1, rendering a more potent neuronal network for voluntary&#xD;
      recruitment. By studying the efficacy of priming as measured by the amount of cortical&#xD;
      excitability in both ipsilesional and contralesional hemispheres, a more advantageous&#xD;
      delivery of rTMS may be realized and eventually incorporated into research trials and&#xD;
      clinical practice. The study poses significant innovation as it explores the role of&#xD;
      metaplasticity in rehabilitation using rTMS. The investigators will employ a double-blind&#xD;
      crossover study using twelve adult participants with stroke. Because of heterogeneity in&#xD;
      stroke type and location between subjects, a crossover design will reduce variability as each&#xD;
      subject serves as their own control.&#xD;
&#xD;
      Specific Aim #1: Compare the effect of 6-Hz primed vs. unprimed low-frequency rTMS on&#xD;
      cortical excitability in chronic stroke.Cortical excitability will be explored with TMS using&#xD;
      ipsilesional paired-pulse testing, cortical silent period testing, and interhemispheric&#xD;
      inhibition (IHI) paired-pulse testing.&#xD;
&#xD;
      Working hypotheses are:&#xD;
&#xD;
        1. Primed rTMS will result in greater increases in the 3-ms and 15-ms ipsilesional&#xD;
           paired-pulse to single-pulse (ipsilesional PP/SP) ratios than unprimed rTMS, indicating&#xD;
           of decreased intracortical inhibition (GABAA-mediated) and greater intracortical&#xD;
           facilitation, respectively.&#xD;
&#xD;
        2. Primed rTMS will result in greater decreases than unprimed rTMS in duration of cortical&#xD;
           silent period, indicating decreased inhibition (GABAB-mediated).&#xD;
&#xD;
        3. Primed rTMS will result in a greater increase in the IHI PP/SP ratio in the non-stroke&#xD;
           to stroke hemisphere direction and a corresponding decrease in the IHI PP/SP ratio in&#xD;
           the stroke to non-stroke hemisphere direction than unprimed rTMS. This is consistent&#xD;
           with less inhibition imparted onto the stroke hemisphere from the non-stroke hemisphere&#xD;
           and greater inhibition imparted on the non-stroke hemisphere from the stroke hemisphere.&#xD;
&#xD;
      Specific Aim #2: Compare the effect of 6-Hz primed vs. unprimed low-frequency rTMS on&#xD;
      functional outcome in chronic stroke. Functional outcome will be assessed by paretic hand&#xD;
      performance on the Box and Block test.&#xD;
&#xD;
      Working hypothesis is:&#xD;
&#xD;
      1. Primed rTMS will result in greater improvements on the Box and Block test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Cortical Excitability: Paired-Pulse</measure>
    <time_frame>Change from Baseline to 20 minutes</time_frame>
    <description>Cortical Excitability of the primary motor cortex on the stroke hemisphere will be assessed using paired-pulse transcranial magnetic stimulation.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>6-Hz Priming</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>real 6-Hz primed low-frequency rTMS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham 6-Hz Priming</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham 6-Hz Primed low-frequency rTMS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Real 1-Hz rTMS only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>real 1-Hz rTMS only</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>real 6-Hz primed low-frequency rTMS</intervention_name>
    <description>10 minutes of 6-Hz stimulation (real priming) followed by 10 minutes of 1-Hz low-frequency stimulation delivered to the nonstroke primary motor region</description>
    <arm_group_label>6-Hz Priming</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham 6-Hz Primed low-frequency rTMS</intervention_name>
    <description>10 minutes of sham priming stimulation followed by 10 minutes of 1-Hz low-frequency stimulation delivered to the nonstroke primary motor region</description>
    <arm_group_label>Sham 6-Hz Priming</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>real 1-Hz rTMS only</intervention_name>
    <description>20 minutes of low-frequency rTMS delivered to the nonstroke primary motor region</description>
    <arm_group_label>Real 1-Hz rTMS only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  presence of stroke at least six months duration&#xD;
&#xD;
          -  demonstrate at least 10 degrees of active extension at the paretic index finger&#xD;
             (metacarpophalangeal joint)&#xD;
&#xD;
          -  possess resting motor evoked potential on the stroke hemisphere with TMS testing&#xD;
&#xD;
          -  Upper Extremity Fugl Meyer score at least 20 out of 66&#xD;
&#xD;
          -  Beck Depression Inventory equal to or less than 19 out of 63&#xD;
&#xD;
          -  Mini-Mental State Examination score at least 24 out of 30&#xD;
&#xD;
          -  age-appropriate receptive language ability&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of seizure within the last two years&#xD;
&#xD;
          -  indwelling metal or medical devices incompatible with TMS&#xD;
&#xD;
          -  anosognosia&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  any co-morbidities impairing upper extremity function (e.g. fracture)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James R Carey, PhD, PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>December 18, 2012</study_first_submitted>
  <study_first_submitted_qc>December 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2012</study_first_posted>
  <results_first_submitted>December 4, 2015</results_first_submitted>
  <results_first_submitted_qc>October 24, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">December 2, 2017</results_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>rTMS</keyword>
  <keyword>TMS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>All subjects received all 3 interventions</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>6-Hz Priming</title>
          <description>real 6-Hz primed low-frequency rTMS&#xD;
real 6-Hz primed low-frequency rTMS: 10 minutes of 6-Hz stimulation (real priming) followed by 10 minutes of 1-Hz low-frequency stimulation delivered to the nonstroke primary motor region&#xD;
Sham 6-Hz Primed low-frequency rTMS&#xD;
real 1-Hz rTMS only&#xD;
real 1-Hz rTMS only: 20 minutes of low-frequency rTMS delivered to the nonstroke primary motor region&#xD;
Sham 6-Hz Primed low-frequency rTMS: 10 minutes of sham priming stimulation followed by 10 minutes of 1-Hz low-frequency stimulation delivered to the nonstroke primary motor region</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11">11 subjects</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10">10 subjects</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Real 6-Hz Priming Sham 6-Hz Priming Real 1-Hz rTMS Only</title>
          <description>real 6-Hz primed low-frequency rTMS&#xD;
real 6-Hz primed low-frequency rTMS:&#xD;
Sham 6-Hz Primed low-frequency rTMS&#xD;
real 1-Hz rTMS only</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66" spread="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Cortical Excitability: Paired-Pulse</title>
        <description>Cortical Excitability of the primary motor cortex on the stroke hemisphere will be assessed using paired-pulse transcranial magnetic stimulation.</description>
        <time_frame>Change from Baseline to 20 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Real 6-Hz Priming</title>
            <description>real 6-Hz primed low-frequency rTMS&#xD;
real 6-Hz primed low-frequency rTMS: 10 minutes of 6-Hz stimulation (real priming) followed by 10 minutes of 1-Hz low-frequency stimulation delivered to the nonstroke primary motor region</description>
          </group>
          <group group_id="O2">
            <title>Sham 6-Hz Priming</title>
            <description>Sham 6-Hz Primed low-frequency rTMS&#xD;
Sham 6-Hz Primed low-frequency rTMS: 10 minutes of sham priming stimulation followed by 10 minutes of 1-Hz low-frequency stimulation delivered to the nonstroke primary motor region</description>
          </group>
          <group group_id="O3">
            <title>Real 1-Hz rTMS Only</title>
            <description>real 1-Hz rTMS only&#xD;
real 1-Hz rTMS only: 20 minutes of low-frequency rTMS delivered to the nonstroke primary motor region</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Cortical Excitability: Paired-Pulse</title>
          <description>Cortical Excitability of the primary motor cortex on the stroke hemisphere will be assessed using paired-pulse transcranial magnetic stimulation.</description>
          <units>milivolt</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-18" spread="14"/>
                    <measurement group_id="O2" value="18" spread="9"/>
                    <measurement group_id="O3" value="12" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Real 6-Hz Priming</title>
          <description>real 6-Hz primed low-frequency rTMS&#xD;
real 6-Hz primed low-frequency rTMS: 10 minutes of 6-Hz stimulation (real priming) followed by 10 minutes of 1-Hz low-frequency stimulation delivered to the nonstroke primary motor region</description>
        </group>
        <group group_id="E2">
          <title>Sham 6-Hz Priming</title>
          <description>Sham 6-Hz Primed low-frequency rTMS&#xD;
Sham 6-Hz Primed low-frequency rTMS: 10 minutes of sham priming stimulation followed by 10 minutes of 1-Hz low-frequency stimulation delivered to the nonstroke primary motor region</description>
        </group>
        <group group_id="E3">
          <title>Real 1-Hz rTMS Only</title>
          <description>real 1-Hz rTMS only&#xD;
real 1-Hz rTMS only: 20 minutes of low-frequency rTMS delivered to the nonstroke primary motor region</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>CTCAE</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Tumor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>James Carey</name_or_title>
      <organization>University of Minnesota</organization>
      <phone>612-626-2746</phone>
      <email>carey007@umn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

